インフォショップ ホームへ 株式会社グローバルインフォメーション
サイトマップ
その他のカテゴリ

商品カタログ

医療/バイオの調査資料販 MEDINFO.JP

先端癌治療特集
BioSeeker Group - 先端癌治療特集ページ 用途別にデータベース、調査資料等をご紹介いたします
BioSeeker Group社
発行

Drug Development China 公式サイト

World Vaccine Congress Australia 2008 公式サイト

Drug Discovery & Development of Innovative Therapeutics India 公式サイト

Discovery2Diagnostics 公式サイト

Discovery On Target 公式サイト

2nd Annual Healthcare Operations Management 公式サイト

Drug Delivery Technology Asia 2008 公式サイト

Post-Approval Drug Safety Strategies 公式サイト
English Korean Chinese
【 英文市場調査報告書 】

産科/婦人科:機会インデックス

Obstetrics and Gynecology: The Opportunity Index

商品コード : 64843 Valid Results, Inc
出版日 : 2008/04
発行 : Valid Results, Inc
電話でのお問い合わせ
価格情報
概要 原文目次
※この商品は英文にてご提供いたします。

Abstract

100 AMA-member (American Medical Association) Ob/Gyn respondents were randomly selected from a list of over 24,000 Ob/Gyns to participate in a self-administered questionnaire (SAQ) featured on the internet.

The purpose of the study is to develop an overview of the perceived positioning of 21 featured medical device and 16 pharmaceutical companies, as well as the considerations associated with determining a company' s position.

The results feature a summary of Ob/Gyn surgeons' perceptions on the importance of specific considerations in evaluating manufacturers. Each featured company is positioned based on their performance on the considerations. The analysis includes a multivariate metric to compare the relative positioning of competing manufacturers. Also included is a positioning of competitive manufacturers based on the perceived strength of association with listed qualities.

The results of the data analysis indicate there are several of leading companies currently servicing Ob/Gyns. Among the device companies, Ethicon' s performance is perceived to be highest on all considerations. Berlex Laboratories is perceived to perform highest on 7 of 10 considerations, relative to the featured pharmaceutical companies.

The information has applicability to advertising, sales, communications, product launches, forecasting, and strategic planning, as well as other business functions.

Table of Contents

Introduction & Report Overview

  • Abstract
  • Measurement Objectives
  • Sample design and distribution/Measurement and Date Collection Design
  • How to read this report

Executive Summary & Key Findings

Detailed Findings

I. Importance

  • a. Important considerations influencing product preferences
  • b. Ratings of importance considerations

II. Awareness & Associations

  • a. Awareness and experience with featured medical device manufacturers
  • b. Awareness and experience with featured pharmaceutical companies
  • c. Top of mind products for featured manufacturers
  • d. Top of mind manufacturer for featured considerations

III. Performance

  • a. “Best” overall company
  • b. “Worst” overall company
  • c. Medical Device Manufacturer - Performance ratings
  • d. Medical Device Standardized by Column/Consideration
  • e. Medical Device Standardized by Row/Manufacturer
  • f. Medical Device Companies Importance/Performance Gap
  • g. Medical Device Positioning on Importance/Performance Rating
  • h. Pharmaceutical Companies-Performance ratings
  • i. Pharmaceutical Standardized by Column/Consideration
  • j. Pharmaceutical Standardized by Row/Manufacturer
  • k. Pharmaceutical Companies Importance/Performance Gap
  • l. Pharmaceutical Companies' Positioning on Importance/Performance Rating

Suggested Additional Analysis

About the Author / Valid Results

概要 原文目次
※この商品は英文にてご提供いたします。
【 英文市場調査報告書 】
産科/婦人科:機会インデックス
Obstetrics and Gynecology: The Opportunity Index
出版日 : 2008/04
電話でのお問い合わせ
この商品について問い合わせる
この商品のサンプル(抜粋)を見る
価格

※ドル建て価格の商品のお支払いは、銀行レート (TTS: 107.78) 換算による円建てのご請求書にて承ります。

US $ 7,500 換算 -> ¥ 808,350 (税抜) PDF By E-mail (Single User License)
US $ 10,000 換算 -> ¥ 1,077,800 (税抜) PDF By E-mail (Global Site License)
商品コード : 64843
関連する商品をキーワードで検索する